GLP-1 / Metabolic
Orforglipron
Also known as: LY3502970
Orforglipron (brand name Foundayo) is Eli Lilly's oral non-peptide small-molecule GLP-1 receptor agonist. Unlike oral semaglutide (Rybelsus), it does not require the SNAC absorption enhancer or fasting/water restrictions — it can be taken any time of day. Not a peptide.
Vendors carrying Orforglipron
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
Independent evidence
All 1 COAs for Orforglipron →COAs for Orforglipron
1 third-party test across 1 vendor. Each card links to the full report.